CIK 1910456
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 75.72% | 19 |
| Unclassified | 24.27% | 3 |
| Life Sciences Tools & Services | 0.01% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | STOK | Stoke Therapeutics, Inc. | Health Care | 24.51% |
| 2 | GHRS | GH RESEARCH PLC | Unclassified | 23.92% |
| 3 | CGEM | Cullinan Therapeutics, Inc. | Health Care | 20.13% |
| 4 | AGIO | AGIOS PHARMACEUTICALS, INC. | Health Care | 13.96% |
| 5 | DNLI | Denali Therapeutics Inc. | Health Care | 5.71% |
| 6 | CCCC | C4 Therapeutics, Inc. | Health Care | 2.91% |
| 7 | KRRO | Korro Bio, Inc. | Health Care | 2.75% |
| 8 | TCRX | TScan Therapeutics, Inc. | Health Care | 1.28% |
| 9 | XNCR | Xencor Inc | Health Care | 1.02% |
| 10 | DTIL | PRECISION BIOSCIENCES INC | Health Care | 0.86% |
20/23 names classified · sector 75.7% of weight · industry 75.7% · mkt cap 75.7%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 75.7% of the book is sector-classified (unclassified names shown, never dropped).
Only 0% of book weight classified — the grid is NOT representative of the whole book.
Classified: 0.0% of book weight (1/23 names) · unclassified 100.0%: STOK, GHRS, CGEM, AGIO, DNLI, CCCC, KRRO, TCRX, XNCR, DTIL +12 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | STOKSTOKE THERAPEUTICS INC | 4,763,673 | $155M | 24.5% | TRIM −12% |
| 2 | GHRSGH RESEARCH PLC | 10,763,288 | $151M | 23.9% | ADD 3% |
| 3 | CGEMCULLINAN THERAPEUTICS INC | 8,963,500 | $127M | 20.1% | HOLD |
| 4 | AGIOAGIOS PHARMACEUTICALS INC | 2,611,568 | $88M | 14.0% | ADD 3180% |
| 5 | DNLIDENALI THERAPEUTICS INC | 1,880,303 | $36M | 5.7% | ADD 8% |
| 6 | CCCCC4 THERAPEUTICS INC | 6,998,902 | $18M | 2.9% | HOLD |
| 7 | KRROKORRO BIO INC | 1,538,296 | $17M | 2.8% | ADD 127% |
| 8 | TCRXTSCAN THERAPEUTICS INC | 8,019,148 | $8M | 1.3% | HOLD |
| 9 | XNCRXENCOR INC | 536,398 | $6M | 1.0% | TRIM −24% |
| 10 | DTILPRECISION BIOSCIENCES INC | 985,113 | $5M | 0.9% | HOLD |
| 11 | PASGPASSAGE BIO INC | 623,704 | $5M | 0.8% | HOLD |
| 12 | NEUPNEUPHORIA THERAPEUTICS INC | 875,328 | $4M | 0.6% | HOLD |
| 13 | TRDAENTRADA THERAPEUTICS INC | 211,689 | $3M | 0.4% | ADD 310% |
| 14 | CGONCG ONCOLOGY INC | 31,591 | $2M | 0.3% | HOLD |
| 15 | IMTXIMMATICS N.V | 216,973 | $2M | 0.3% | TRIM −76% |
| 16 | DSGNDESIGN THERAPEUTICS INC | 119,516 | $1M | 0.2% | ADD 72% |
| 17 | VYNEVYNE THERAPEUTICS INC | 1,628,700 | $973,148 | 0.2% | NEW |
| 18 | HOWLWEREWOLF THERAPEUTICS INC | 657,786 | $547,673 | 0.1% | HOLD |
| 19 | IBIOIBIO INC | 68,076 | $129,344 | 0.0% | NEW |
| 20 | BOLTBOLT BIOTHERAPEUTICS INC | 30,800 | $124,432 | 0.0% | NEW |
| 21 | PRQRPROQR THRAPEUTICS N V | 68,486 | $110,947 | 0.0% | HOLD |
| 22 | ABSIABSCI CORPORATION | 21,245 | $63,735 | 0.0% | NEW |
| 23 | TRAWTRAWS PHARMA INC | 15,078 | $27,593 | 0.0% | NEW |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| STOKSTOKE THERAPEUTICS INC | 5.2M | 5.3M | 5.4M | 5.4M | 5.4M | 4.8M | $155M |
| GHRSGH RESEARCH PLC | 4.9M | 6.4M | 6.7M | 8.6M | 10.4M | 10.8M | $151M |
| CGEMCULLINAN THERAPEUTICS INC | 1.3M | 3.2M | 4.4M | 5.8M | 9.0M | 9.0M | $127M |
| AGIOAGIOS PHARMACEUTICALS INC | — | — | — | — | 80K | 2.6M | $88M |
| DNLIDENALI THERAPEUTICS INC | — | — | — | 262K | 1.7M | 1.9M | $36M |
| CCCCC4 THERAPEUTICS INC | 6.9M | 7.1M | 7.1M | 7.1M | 7.1M | 7.0M | $18M |
| KRROKORRO BIO INC | — | — | — | — | 678K | 1.5M | $17M |
| TCRXTSCAN THERAPEUTICS INC | 5.4M | 5.4M | 7.9M | 7.9M | 8.0M | 8.0M | $8M |
| XNCRXENCOR INC | — | — | — | — | 706K | 536K | $6M |
| DTILPRECISION BIOSCIENCES INC | 766K | 766K | 1.0M | 1.0M | 994K | 985K | $5M |
| PASGPASSAGE BIO INC | — | — | — | 624K | 624K | 624K | $5M |
| NEUPNEUPHORIA THERAPEUTICS INC | 46K | 46K | 46K | — | 875K | 875K | $4M |
| TRDAENTRADA THERAPEUTICS INC | — | — | — | — | 52K | 212K | $3M |
| CGONCG ONCOLOGY INC | — | — | — | — | 32K | 32K | $2M |
| IMTXIMMATICS N.V | — | — | — | — | 922K | 217K | $2M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
